You searched for T cells - Page 26 of 41

In Depth 3 Nov 2022

What’s on the horizon for gene editing-based therapies?

…Arbor Biotechnologies. He added that much of the interest in the technology is its potential to not just treat diseases, but to cure them. The most advanced CRISPR-based cell therapies…

November 3, 2022 - 8 minutesmins - By Jonathan Smith

News and Trends 12 Sep 2017

Norwegian Biotech Announces Positive Phase I Results for T cell-Stimulating Vaccine

…the integrity of the vesicle membrane, freeing the drug to perform its role in the target cell. The mechanism by which PCI technology helps therapeutic drugs to enter target cells….

September 12, 2017 - 2 minutesmins - By Alex Dale

In Depth 17 Jan 2025

Are PD-1 and PD-L1 checkpoint inhibitors as good as we thought?

…that may not have that rationale,” Masoud Tavazoie told Labiotech, a few years ago. “Over the next two to three years, we’re gonna start to see the real winners. And…

January 17, 2025 - 7 minutesmins - By Roohi Mariam Peter

stem cell therapy mogrify disley heart disease

Startup Scout 22 Feb 2019

This Biotech’s Algorithm Accelerates Cell Therapy Development

…them into the therapeutic cell that you want. This is not a simple process, and it can take significant amounts of time and money. The stem cell stage can be…

February 22, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 13 Dec 2017

Biotech and Pharma Giants Make a Good Start to Phase II Trial for Skin Cancer

…mechanisms used by tumors to protect themselves from the immune system. In particular, PD-1 tells T cells not to attack cells that express its ligand, PD-L1. Checkpoint inhibitors that block…

December 13, 2017 - 3 minutesmins - By Alex Dale

CRISPR Therapeutics, CRISPR-Cas9, genome editing, biotech

News and Trends 9 Aug 2022

Study says gene editing with CRISPR/Cas9 can lead to cell toxicity and genome instability

…that cells that overcome CRISPR editing might do so precisely because of defective p53 functioning. That is to say, these cells may be less able to detect DNA damage and/or…

August 9, 2022 - 3 minutesmins - By Jim Cornall

Best in Biotech 28 Feb 2023

10 biotech companies making a difference in rare diseases

…part of a drug regimen to treat chronic granulomatous disease (CGD); Buphenyl, used to treat urea cycle disorders; Krystexxa, to treat gout; Procysbi, to treat nephropathic cystinosis; Ravicti, to manage…

February 28, 2023 - 11 minutesmins - By Willow Shah-Neville

News and Trends 2 Jun 2023

Faux filet: World’s first 3D-printed ready-to-cook fish produced

…that are grown in laboratories, are obtained from the startup’s proprietary 3D bioprinters and customized bio-inks. Said to have the same taste and texture as traditionally caught fish, this invention…

June 2, 2023 - 3 minutesmins - By Roohi Mariam Peter

News and Trends 30 Jan 2018

Two Biotechs Team Up to Test their Cancer Antibody Combo in the Clinic

…a Phase I trial to select a dose that can be used at Phase II to test the combination’s safety and efficacy. Durvalumab is a checkpoint inhibitor that blocks PD-L1…

January 30, 2018 - 3 minutesmins - By Alex Dale

CRISPR, CRISPR-Cas9, genome-editing, gene therapy

News and Trends 8 Sep 2022

CRISPR/CAS9 strategic alliance between Sigma-Aldrich and genOway expanded

…all rodent cells derived from these genetically modified rodent animals. It also includes the genetic manipulation of rodent embryonic stem cells and rodent embryos to create genetically modified rodent animals….

September 8, 2022 - 3 minutesmins - By Liza Laws

News and Trends 28 Sep 2018

Roche Acquires UK Cancer Immunotherapy Biotech in Deal Worth up to €655M

…cells called regulatory T cells. These cells hold back the immune system from attacking tumors, thus the antibody helps the patient’s immune system to fight the cancer. The antibody has…

September 28, 2018 - 2 minutesmins - By Jonathan Smith

Best in Biotech 5 Mar 2025

Seven biotech companies keeping Taiwan dynamic in 2025

…cytotoxic agent specifically to TROP2-expressing cancer cells, to minimize damage to normal tissues. Preclinical studies have demonstrated promising anti-tumor activity, leading to the advancement of OBI-992 into clinical development. In…

March 5, 2025 - 8 minutesmins - By Jules Adam

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: T cells

What’s on the horizon for gene editing-based therapies?

Norwegian Biotech Announces Positive Phase I Results for T cell-Stimulating Vaccine

Are PD-1 and PD-L1 checkpoint inhibitors as good as we thought?

This Biotech’s Algorithm Accelerates Cell Therapy Development

Biotech and Pharma Giants Make a Good Start to Phase II Trial for Skin Cancer

Study says gene editing with CRISPR/Cas9 can lead to cell toxicity and genome instability

10 biotech companies making a difference in rare diseases

Faux filet: World’s first 3D-printed ready-to-cook fish produced

Two Biotechs Team Up to Test their Cancer Antibody Combo in the Clinic

CRISPR/CAS9 strategic alliance between Sigma-Aldrich and genOway expanded

Roche Acquires UK Cancer Immunotherapy Biotech in Deal Worth up to €655M

Seven biotech companies keeping Taiwan dynamic in 2025

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!